Interaction between p53 and estradiol pathways in transcriptional responses to chemotherapeutics

References

• Espinosa JM. Mechanisms of regulatory diversity within the p53 transcriptional network. Oncogene 2008; 27:4013 - 23; http://dx.doi.org/10.1038/onc.2008.37; PMID: 18278067
   PubMed Web of Science ®Google Scholar
• Pan Y, Tsai C-J, Ma B, Nussinov R. Mechanisms of transcription factor selectivity. Trends Genet 2010; 26:75 - 83; http://dx.doi.org/10.1016/j.tig.2009.12.003; PMID: 20074831
   PubMed Web of Science ®Google Scholar
• Bode AM, Dong Z. Post-translational modification of p53 in tumorigenesis. Nat Rev Cancer 2004; 4:793 - 805; http://dx.doi.org/10.1038/nrc1455; PMID: 15510160
   PubMed Web of Science ®Google Scholar
• Levine AJ, Oren M. The first 30 years of p53: growing ever more complex. Nat Rev Cancer 2009; 9:749 - 58; http://dx.doi.org/10.1038/nrc2723; PMID: 19776744
   PubMed Web of Science ®Google Scholar
• Menendez D, Inga A, Resnick MA. Potentiating the p53 network. Discov Med 2010; 10:94 - 100; PMID: 20670604
   PubMed Web of Science ®Google Scholar
• Vousden KH, Prives C. Blinded by the Light: The Growing Complexity of p53. Cell 2009; 137:413 - 31; http://dx.doi.org/10.1016/j.cell.2009.04.037; PMID: 19410540
   PubMed Web of Science ®Google Scholar
• Vousden KH, Ryan KM. p53 and metabolism. Nat Rev Cancer 2009; 9:691 - 700; http://dx.doi.org/10.1038/nrc2715; PMID: 19759539
   PubMed Web of Science ®Google Scholar
• Dahlman-Wright K, Cavailles V, Fuqua SA, Jordan VC, Katzenellenbogen JA, Korach KS, et al. International Union of Pharmacology. LXIV. Estrogen receptors. Pharmacol Rev 2006; 58:773 - 81; http://dx.doi.org/10.1124/pr.58.4.8; PMID: 17132854
   PubMed Web of Science ®Google Scholar
• Deroo BJ, Korach KS. Estrogen receptors and human disease. J Clin Invest 2006; 116:561 - 70; http://dx.doi.org/10.1172/JCI27987; PMID: 16511588
   PubMed Web of Science ®Google Scholar
• Heldring N, Pike A, Andersson S, Matthews J, Cheng G, Hartman J, et al. Estrogen receptors: how do they signal and what are their targets. Physiol Rev 2007; 87:905 - 31; http://dx.doi.org/10.1152/physrev.00026.2006; PMID: 17615392
   PubMed Web of Science ®Google Scholar
• Konduri SD, Medisetty R, Liu W, Kaipparettu BA, Srivastava P, Brauch H, et al. Mechanisms of estrogen receptor antagonism toward p53 and its implications in breast cancer therapeutic response and stem cell regulation. Proc Natl Acad Sci USA 2010; 107:15081 - 6; http://dx.doi.org/10.1073/pnas.1009575107; PMID: 20696891
   PubMed Web of Science ®Google Scholar
• Liu W, Ip MM, Podgorsak MB, Das GM. Disruption of estrogen receptor α-p53 interaction in breast tumors: a novel mechanism underlying the anti-tumor effect of radiation therapy. Breast Cancer Res Treat 2009; 115:43 - 50; http://dx.doi.org/10.1007/s10549-008-0044-z; PMID: 18481172
   PubMed Web of Science ®Google Scholar
• Liu W, Konduri SD, Bansal S, Nayak BK, Rajasekaran SA, Karuppayil SM, et al. Estrogen receptor-α binds p53 tumor suppressor protein directly and represses its function. J Biol Chem 2006; 281:9837 - 40; http://dx.doi.org/10.1074/jbc.C600001200; PMID: 16469747
   PubMed Web of Science ®Google Scholar
• Sayeed A, Konduri SD, Liu W, Bansal S, Li F, Das GM. Estrogen receptor α inhibits p53-mediated transcriptional repression: implications for the regulation of apoptosis. Cancer Res 2007; 67:7746 - 55; http://dx.doi.org/10.1158/0008-5472.CAN-06-3724; PMID: 17699779
   PubMed Web of Science ®Google Scholar
• Liu G, Schwartz JA, Brooks SC. p53 down-regulates ER-responsive genes by interfering with the binding of ER to ERE. Biochem Biophys Res Commun 1999; 264:359 - 64; http://dx.doi.org/10.1006/bbrc.1999.1525; PMID: 10529369
   PubMed Web of Science ®Google Scholar
• Yu C-L, Driggers P, Barrera-Hernandez G, Nunez SB, Segars JH, Cheng S-y. The tumor suppressor p53 is a negative regulator of estrogen receptor signaling pathways. Biochem Biophys Res Commun 1997; 239:617 - 20; http://dx.doi.org/10.1006/bbrc.1997.7522; PMID: 9344880
   PubMed Web of Science ®Google Scholar
• Fernández-Cuesta L, Anaganti S, Hainaut P, Olivier M. Estrogen levels act as a rheostat on p53 levels and modulate p53-dependent responses in breast cancer cell lines. Breast Cancer Res Treat 2011; 125:35 - 42; http://dx.doi.org/10.1007/s10549-010-0819-x; PMID: 20221692
   PubMed Web of Science ®Google Scholar
• Angeloni SV, Martin MB, Garcia-Morales P, Castro-Galache MD, Ferragut JA, Saceda M. Regulation of estrogen receptor-alpha expression by the tumor suppressor gene p53 in MCF-7 cells. J Endocrinol 2004; 180:497 - 504; http://dx.doi.org/10.1677/joe.0.1800497; PMID: 15012604
   PubMed Web of Science ®Google Scholar
• Miller LD, Smeds J, George J, Vega VB, Vergara L, Ploner A, et al. An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival. Proc Natl Acad Sci USA 2005; 102:13550 - 5; http://dx.doi.org/10.1073/pnas.0506230102; PMID: 16141321
   PubMed Web of Science ®Google Scholar
• Olivier M, Langerød A, Carrieri P, Bergh J, Klaar S, Eyfjord J, et al. The clinical value of somatic TP53 gene mutations in 1,794 patients with breast cancer. Clin Cancer Res 2006; 12:1157 - 67; http://dx.doi.org/10.1158/1078-0432.CCR-05-1029; PMID: 16489069
   PubMed Web of Science ®Google Scholar
• Duong V, Boulle N, Daujat S, Chauvet J, Bonnet S, Neel H, et al. Differential regulation of estrogen receptor α turnover and transactivation by Mdm2 and stress-inducing agents. Cancer Res 2007; 67:5513 - 21; http://dx.doi.org/10.1158/0008-5472.CAN-07-0967; PMID: 17545634
   PubMed Web of Science ®Google Scholar
• Kim K, Burghardt R, Barhoumi R, Lee SO, Liu X, Safe S. MDM2 regulates estrogen receptor α and estrogen responsiveness in breast cancer cells. J Mol Endocrinol 2011; 46:67 - 79; PMID: 21169420
   PubMed Web of Science ®Google Scholar
• Ciribilli Y, Andreotti V, Menendez D, Langen J-S, Schoenfelder G, Resnick MA, et al. The coordinated p53 and estrogen receptor cis-regulation at an FLT1 promoter SNP is specific to genotoxic stress and estrogenic compound. PLoS ONE 2010; 5:e10236; http://dx.doi.org/10.1371/journal.pone.0010236; PMID: 20422012
   PubMedGoogle Scholar
• Menendez D, Inga A, Snipe J, Krysiak O, Schönfelder G, Resnick MA. A single-nucleotide polymorphism in a half-binding site creates p53 and estrogen receptor control of vascular endothelial growth factor receptor 1. Mol Cell Biol 2007; 27:2590 - 600; http://dx.doi.org/10.1128/MCB.01742-06; PMID: 17242190
   PubMed Web of Science ®Google Scholar
• Menendez D, Inga A, Resnick MA. The expanding universe of p53 targets. Nat Rev Cancer 2009; 9:724 - 37; http://dx.doi.org/10.1038/nrc2730; PMID: 19776742
   PubMed Web of Science ®Google Scholar
• Menendez D, Inga A, Resnick MA. Estrogen receptor acting in cis enhances WT and mutant p53 transactivation at canonical and noncanonical p53 target sequences. Proc Natl Acad Sci USA 2010; 107:1500 - 5; http://dx.doi.org/10.1073/pnas.0909129107; PMID: 20080630
   PubMed Web of Science ®Google Scholar
• Menendez D, Krysiak O, Inga A, Krysiak B, Resnick MA, Schönfelder G. A SNP in the flt-1 promoter integrates the VEGF system into the p53 transcriptional network. Proc Natl Acad Sci USA 2006; 103:1406 - 11; http://dx.doi.org/10.1073/pnas.0508103103; PMID: 16432214
   PubMed Web of Science ®Google Scholar
• Carroll JS, Brown M. Estrogen receptor target gene: an evolving concept. Mol Endocrinol 2006; 20:1707 - 14; http://dx.doi.org/10.1210/me.2005-0334; PMID: 16396959
   PubMed Web of Science ®Google Scholar
• Gruber CJ, Gruber DM, Gruber IML, Wieser F, Huber JC. Anatomy of the estrogen response element. Trends in Endocrinology &amp. Metabolism 2004; 15:73 - 8
   Google Scholar
• Joshi SR, Ghattamaneni RB, Scovell WM. Expanding the paradigm for estrogen receptor binding and transcriptional activation. Mol Endocrinol 2011; 25:980 - 94; http://dx.doi.org/10.1210/me.2010-0302; PMID: 21527498
   PubMed Web of Science ®Google Scholar
• Cheok CF, Verma CS, Baselga J, Lane DP. Translating p53 into the clinic. Nat Rev Clin Oncol 2011; 8:25 - 37; http://dx.doi.org/10.1038/nrclinonc.2010.174; PMID: 20975744
   PubMed Web of Science ®Google Scholar
• Huang DW, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 2008; 4:44 - 57; http://dx.doi.org/10.1038/nprot.2008.211
   PubMed Web of Science ®Google Scholar
• Kuhn M, Szklarczyk D, Franceschini A, Campillos M, von Mering C, Jensen LJ, et al. STITCH 2: an interaction network database for small molecules and proteins. Nucleic Acids Res 2010; 38:Database issue D552 - 6; http://dx.doi.org/10.1093/nar/gkp937; PMID: 19897548
   PubMed Web of Science ®Google Scholar
• Jin YJ, Wang J, Qiao C, Hei TK, Brandt-Rauf PW, Yin Y. A novel mechanism for p53 to regulate its target gene ECK in signaling apoptosis. Mol Cancer Res 2006; 4:769 - 78; http://dx.doi.org/10.1158/1541-7786.MCR-06-0178; PMID: 17050670
   PubMed Web of Science ®Google Scholar
• Menendez D, Shatz M, Azzam K, Garantziotis S, Fessler MB, Resnick MA. The Toll-like receptor gene family is integrated into human DNA damage and p53 networks. PLoS Genet 2011; 7:e1001360; http://dx.doi.org/10.1371/journal.pgen.1001360; PMID: 21483755
   PubMed Web of Science ®Google Scholar
• Brummelkamp TR, Bernards R, Agami R. A system for stable expression of short interfering RNAs in mammalian cells. Science 2002; 296:550 - 3; http://dx.doi.org/10.1126/science.1068999; PMID: 11910072
   PubMed Web of Science ®Google Scholar
• Subik K, Lee J-F, Baxter L, Strzepek T, Costello D, Crowley P, et al. The Expression Patterns of ER, PR, HER2, CK5/6, EGFR, Ki-67 and AR by Immunohistochemical Analysis in Breast Cancer Cell Lines. Breast Cancer (Auckl) 2010; 4:35 - 41; PMID: 20697531
   PubMedGoogle Scholar
• Munster PN, Carpenter JT. Estradiol in breast cancer treatment: reviving the past. JAMA 2009; 302:797 - 8; http://dx.doi.org/10.1001/jama.2009.1223; PMID: 19690316
   PubMed Web of Science ®Google Scholar
• Azmi AS, Banerjee S, Ali S, Wang Z, Bao B, Beck FW, et al. Network modeling of MDM2 inhibitor-oxaliplatin combination reveals biological synergy in wt-p53 solid tumors. Oncotarget 2011; 2:378 - 92; PMID: 21623005
   PubMed Web of Science ®Google Scholar
• Deng XS, Wang S, Deng A, Liu B, Edgerton SM, Lind SE, et al. Metformin targets Stat3 to inhibit cell growth and induce apoptosis in triple-negative breast cancers. Cell Cycle 2012; 11:367 - 76; http://dx.doi.org/10.4161/cc.11.2.18813; PMID: 22189713
   PubMed Web of Science ®Google Scholar
• Jiang Z, Jones R, Liu JC, Deng T, Robinson T, Chung PE, et al. RB1 and p53 at the crossroad of EMT and triple-negative breast cancer. Cell Cycle 2011; 10:1563 - 70; http://dx.doi.org/10.4161/cc.10.10.15703; PMID: 21502814
   PubMed Web of Science ®Google Scholar
• Troester MA, Hoadley KA, Parker JS, Perou CM. Prediction of toxicant-specific gene expression signatures after chemotherapeutic treatment of breast cell lines. Environ Health Perspect 2004; 112:1607 - 13; http://dx.doi.org/10.1289/ehp.7204; PMID: 15598611
   PubMed Web of Science ®Google Scholar
• Liu Q, Dumont DJ. Molecular cloning and chromosomal localization in human and mouse of the SH2-containing inositol phosphatase, INPP5D (SHIP). Amgen EST Program. Genomics 1997; 39:109 - 12; http://dx.doi.org/10.1006/geno.1996.4374; PMID: 9027494
   PubMed Web of Science ®Google Scholar
• Kerley-Hamilton JS, Pike AM, Li N, DiRenzo J, Spinella MJ. A p53-dominant transcriptional response to cisplatin in testicular germ cell tumor-derived human embryonal carcinoma. Oncogene 2005; 24:6090 - 100; http://dx.doi.org/10.1038/sj.onc.1208755; PMID: 15940259
   PubMed Web of Science ®Google Scholar
• Badock V, Steinhusen U, Bommert K, Wittmann-Liebold B, Otto A. Apoptosis-induced cleavage of keratin 15 and keratin 17 in a human breast epithelial cell line. Cell Death Differ 2001; 8:308 - 15; http://dx.doi.org/10.1038/sj.cdd.4400812; PMID: 11319614
   PubMed Web of Science ®Google Scholar
• Bailey ST, Shin H, Westerling T, Liu XS, Brown M. Estrogen receptor prevents p53-dependent apoptosis in breast cancer. Proc Natl Acad Sci USA 2012; 109:18060 - 5; http://dx.doi.org/10.1073/pnas.1018858109; PMID: 23077249
   PubMed Web of Science ®Google Scholar
• Kooistra SM, Helin K. Molecular mechanisms and potential functions of histone demethylases. Nat Rev Mol Cell Biol 2012; 13:297 - 311; PMID: 22473470
   PubMed Web of Science ®Google Scholar
• Mund A, Schubert T, Staege H, Kinkley S, Reumann K, Kriegs M, et al. SPOC1 modulates DNA repair by regulating key determinants of chromatin compaction and DNA damage response. Nucleic Acids Res 2012; 40:11363 - 79; http://dx.doi.org/10.1093/nar/gks868; PMID: 23034801
   PubMed Web of Science ®Google Scholar
• Sulli G, Di Micco R, d’Adda di Fagagna F. Crosstalk between chromatin state and DNA damage response in cellular senescence and cancer. Nat Rev Cancer 2012; 12:709 - 20; http://dx.doi.org/10.1038/nrc3344; PMID: 22952011
   PubMed Web of Science ®Google Scholar
• Lee DY, Northrop JP, Kuo MH, Stallcup MR. Histone H3 lysine 9 methyltransferase G9a is a transcriptional coactivator for nuclear receptors. J Biol Chem 2006; 281:8476 - 85; http://dx.doi.org/10.1074/jbc.M511093200; PMID: 16461774
   PubMed Web of Science ®Google Scholar
• An W, Kim J, Roeder RG. Ordered cooperative functions of PRMT1, p300, and CARM1 in transcriptional activation by p53. Cell 2004; 117:735 - 48; http://dx.doi.org/10.1016/j.cell.2004.05.009; PMID: 15186775
   PubMed Web of Science ®Google Scholar
• Cloos PA, Christensen J, Agger K, Helin K. Erasing the methyl mark: histone demethylases at the center of cellular differentiation and disease. Genes Dev 2008; 22:1115 - 40; http://dx.doi.org/10.1101/gad.1652908; PMID: 18451103
   PubMed Web of Science ®Google Scholar
• Garcia-Bassets I, Kwon YS, Telese F, Prefontaine GG, Hutt KR, Cheng CS, et al. Histone methylation-dependent mechanisms impose ligand dependency for gene activation by nuclear receptors. Cell 2007; 128:505 - 18; http://dx.doi.org/10.1016/j.cell.2006.12.038; PMID: 17289570
   PubMed Web of Science ®Google Scholar
• Huang J, Sengupta R, Espejo AB, Lee MG, Dorsey JA, Richter M, et al. p53 is regulated by the lysine demethylase LSD1. Nature 2007; 449:105 - 8; http://dx.doi.org/10.1038/nature06092; PMID: 17805299
   PubMed Web of Science ®Google Scholar
• Tsai WW, Nguyen TT, Shi Y, Barton MC. p53-targeted LSD1 functions in repression of chromatin structure and transcription in vivo. Mol Cell Biol 2008; 28:5139 - 46; http://dx.doi.org/10.1128/MCB.00287-08; PMID: 18573881
   PubMed Web of Science ®Google Scholar
• Espinosa JM, Emerson BM. Transcriptional regulation by p53 through intrinsic DNA/chromatin binding and site-directed cofactor recruitment. Mol Cell 2001; 8:57 - 69; http://dx.doi.org/10.1016/S1097-2765(01)00283-0; PMID: 11511360
   PubMed Web of Science ®Google Scholar
• Hanstein B, Eckner R, DiRenzo J, Halachmi S, Liu H, Searcy B, et al. p300 is a component of an estrogen receptor coactivator complex. Proc Natl Acad Sci USA 1996; 93:11540 - 5; http://dx.doi.org/10.1073/pnas.93.21.11540; PMID: 8876171
   PubMed Web of Science ®Google Scholar
• Collavin L, Lunardi A, Del Sal G. p53-family proteins and their regulators: hubs and spokes in tumor suppression. Cell Death Differ 2010; 17:901 - 11; http://dx.doi.org/10.1038/cdd.2010.35; PMID: 20379196
   PubMed Web of Science ®Google Scholar
• Poyurovsky MV, Katz C, Laptenko O, Beckerman R, Lokshin M, Ahn J, et al. The C terminus of p53 binds the N-terminal domain of MDM2. Nat Struct Mol Biol 2010; 17:982 - 9; http://dx.doi.org/10.1038/nsmb.1872; PMID: 20639885
   PubMed Web of Science ®Google Scholar
• Berteaux N, Lottin S, Monté D, Pinte S, Quatannens B, Coll J, et al. H19 mRNA-like noncoding RNA promotes breast cancer cell proliferation through positive control by E2F1. J Biol Chem 2005; 280:29625 - 36; http://dx.doi.org/10.1074/jbc.M504033200; PMID: 15985428
   PubMed Web of Science ®Google Scholar
• Wang J, Fu L, Gu F, Ma Y. Notch1 is involved in migration and invasion of human breast cancer cells. Oncol Rep 2011; 26:1295 - 303; PMID: 21785827
   PubMed Web of Science ®Google Scholar
• Noetzel E, Rose M, Sevinc E, Hilgers RD, Hartmann A, Naami A, et al. Intermediate filament dynamics and breast cancer: aberrant promoter methylation of the Synemin gene is associated with early tumor relapse. Oncogene 2010; 29:4814 - 25; http://dx.doi.org/10.1038/onc.2010.229; PMID: 20543860
   PubMed Web of Science ®Google Scholar
• Cai Z, Sanchez A, Shi Z, Zhang T, Liu M, Zhang D. Activation of Toll-like receptor 5 on breast cancer cells by flagellin suppresses cell proliferation and tumor growth. Cancer Res 2011; 71:2466 - 75; http://dx.doi.org/10.1158/0008-5472.CAN-10-1993; PMID: 21427357
   PubMed Web of Science ®Google Scholar
• Cowin P, Rowlands TM, Hatsell SJ. Cadherins and catenins in breast cancer. Curr Opin Cell Biol 2005; 17:499 - 508; http://dx.doi.org/10.1016/j.ceb.2005.08.014; PMID: 16107313
   PubMed Web of Science ®Google Scholar
• Udayakumar D, Zhang G, Ji Z, Njauw CN, Mroz P, Tsao H. EphA2 is a critical oncogene in melanoma. Oncogene 2011; 30:4921 - 9; http://dx.doi.org/10.1038/onc.2011.210; PMID: 21666714
   PubMed Web of Science ®Google Scholar
• Zhang G, Njauw C-N, Park JM, Naruse C, Asano M, Tsao H. EphA2 is an essential mediator of UV radiation-induced apoptosis. Cancer Res 2008; 68:1691 - 6; http://dx.doi.org/10.1158/0008-5472.CAN-07-2372; PMID: 18339848
   PubMed Web of Science ®Google Scholar
• Salomoni P, Pandolfi PP. The role of PML in tumor suppression. Cell 2002; 108:165 - 70; http://dx.doi.org/10.1016/S0092-8674(02)00626-8; PMID: 11832207
   PubMed Web of Science ®Google Scholar
• Luo JM, Liu ZL, Hao HL, Wang FX, Dong ZR, Ohno R. Mutation analysis of SHIP gene in acute leukemia. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2004; 12:420 - 6; PMID: 15363123
   PubMedGoogle Scholar
• Zhou M-N, Kunttas-Tatli E, Zimmerman S, Zhouzheng F, McCartney BM. Cortical localization of APC2 plays a role in actin organization but not in Wnt signaling in Drosophila. J Cell Sci 2011; 124:1589 - 600; http://dx.doi.org/10.1242/jcs.073916; PMID: 21486956
   PubMed Web of Science ®Google Scholar
• Shetty PJ, Movva S, Pasupuleti N, Vedicherlla B, Vattam KK, Venkatasubramanian S, et al. Regulation of IGF2 transcript and protein expression by altered methylation in breast cancer. J Cancer Res Clin Oncol 2011; 137:339 - 45; http://dx.doi.org/10.1007/s00432-010-0890-z; PMID: 20422427
   PubMed Web of Science ®Google Scholar
• Uhlen M, Oksvold P, Fagerberg L, Lundberg E, Jonasson K, Forsberg M, et al. Towards a knowledge-based Human Protein Atlas. Nat Biotechnol 2010; 28:1248 - 50; http://dx.doi.org/10.1038/nbt1210-1248; PMID: 21139605
   PubMed Web of Science ®Google Scholar
• Breitling R, Armengaud P, Amtmann A, Herzyk P. Rank products: a simple, yet powerful, new method to detect differentially regulated genes in replicated microarray experiments. FEBS Lett 2004; 573:83 - 92; http://dx.doi.org/10.1016/j.febslet.2004.07.055; PMID: 15327980
   PubMed Web of Science ®Google Scholar
• Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 2002; 3:research0034.1 - research.11; H0034 http://dx.doi.org/10.1186/gb-2002-3-7-research0034; PMID: 12184808
   PubMed Web of Science ®Google Scholar
• Thomas-Chollier M, Defrance M, Medina-Rivera A, Sand O, Herrmann C, Thieffry D, et al. RSAT 2011: regulatory sequence analysis tools. Nucleic Acids Res 2011; 39:suppl W86 - 91; http://dx.doi.org/10.1093/nar/gkr377; PMID: 21715389
   PubMed Web of Science ®Google Scholar